InvestorsHub Logo
icon url

foxi

09/19/22 10:29 PM

#159907 RE: pumper_stumper #159904

So the statement phrased as a question had no basis in reality, then? lol

Of course a question can be backed up with links? That's what makes a question informed, yes? Anyway, here are a couple of links that do provide a basis in something cite-able?

On October 7, 2021, the Company entered into a MDSA and PSA with Samsung Biologics Co., Ltd to advance the development of the Company’s human clone antibody program and clinical testing.

Quarterly Report for period 06.30.2022, page 12



After confirming antibody activity, the Company's CDMO partner Samsung Biologics produces recombinant antibodies in their proprietary, FDA-approved stable CHO cell line suitable for Clinical Application.

Quarterly Report for period 06.30.2022, page 17



So as we can see, Samsung is still working with ENZC according to the 2022 Q2 filings, and they really do have an ongoing partnership?




.